ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A prognosis-related molecular subtype for early-stage non-small lung cell carcinoma by multi-omics integration analysis

Yang, Kai; Wu, Ying*南方医科大学; 1; y
BMC CANCER2021-2-6DOI: 10.1186/s12885-021-07846-0
6被引8阅读
引用收藏
分享

摘要

Background Early-stage non-small cell lung carcinoma (NSCLC) accounts for more than 80% of lung cancer, which is a kind of cancer with high heterogeneity, so the genetic heterogeneity and molecular subtype should be explored. Methods Partitioning Around Medoid algorithm was used to acquire the molecular subtype for early-stage NSCLC based on prognosis-related mRNAs and methylation sites. Random forest (RF) and support vector machine (SVM) were used to build prediction models for subtypes. Results Six prognosis-related subtypes for early-stage NSCLC, including 4 subtypes for lung squamous cell carcinoma (LUSC) and 2 subtypes for lung adenocarcinoma (LUAD), were identified. There were highly expressed and hypermethylated gene regions for LUSC-C1 and LUAD-C2, highly expressed region for LUAD-C1, and hypermethylated regions for LUSC-C3 and LUSC-C4. Molecular subtypes for LUSC were mainly determined by DNA methylation (14 mRNAs and 362 methylation sites). Molecular subtypes for LUAD were determined by both mRNA and DNA methylation information (143 mRNAs and 458 methylation sites). Ten methylation sites were selected as biomarkers for prediction of LUSC-C1 and LUSC-C3, respectively. Nine genes and 1 methylation site were selected as biomarkers for LUAD subtype prediction. These subtypes can be predicted by the selected biomarkers with RF and SVM models. Conclusions In conclusion, we proposed a prognosis-related molecular subtype for early-stage NSCLC, which can provide important information for personalized therapy of patients.

学科与关键词

关键词
Early-stage lung cancerMolecular subtypePrognosisGene expressionDNA methylation
相关
加载中…
  • Molecular subtypes based on DNA methylation predict prognosis in lung squamous cell carcinoma
    Li Xiu Shen; Nie Ke Chao; Zheng Zhi Hua; Zhou Rui Sheng; Huang Yu Sheng; Ye Zeng Jie; He Fan; Tang YingBMC Cancer, 2021, 21(1).
  • Mining the Prognostic Role of DNA Methylation Heterogeneity in Lung Adenocarcinoma
    Liao, Hongying; Luo, Xiaolong; Huang, Yisheng; Yang, Xingping; Zheng, Yuzhen; Qin, Xianyu; Tan, Jian; Shen, Piao; Tian, Renjiang; Cai, Weijie; Shi, Xiaoshun*; Deng, Xiaofang*DISEASE MARKERS, 2022, 2022: 9389372.
  • DNA methylation-based lung adenocarcinoma subtypes can predict prognosis, recurrence, and immunotherapeutic implications
    Xu, Feng; He, Lulu; Zhan, Xueqin; Chen, Jiexin; Xu, Huan; Huang, Xiaoling; Li, Yangyi; Zheng, Xiaohe; Lin, Ling*; Chen, Yongsong*Aging-US, 2020, 12(24): 25275-25293.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
BMC CANCER
发表日期
2021-02-06
卷期
第 21 卷, 第 1 期
页码
128
DOI
10.1186/s12885-021-07846-0
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81703322]; China Postdoctoral Science Foundation [2020 M673082]

作者

  • Y

    Yang, Kai (第一作者)

    2 · 1

  • W

    Wu, Ying (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417